T1	PROC 44 89	Estudio multicéntrico, aleatorizado y abierto
T2	PROC 105 116	tratamiento
#1	AnnotatorNotes T2	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T3	CHEM 134 146	carboplatino
#2	AnnotatorNotes T3	C0079083; carboplatin; Organic Chemical · Pharmacologic Substance
T4	CHEM 149 159	paclitaxel
#3	AnnotatorNotes T4	C0144576; paclitaxel; Organic Chemical · Pharmacologic Substance
T5	PROC 170 196	tratamiento quimioterápico
T6	PROC 1814 1820	tratar
#4	AnnotatorNotes T6	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T7	DISO 247 256	fumadores
#5	AnnotatorNotes T7	C0337664; Smoker; Finding
T8	DISO 259 271	ex fumadores
#6	AnnotatorNotes T8	C2911355; Personal History of Nicotine Dependence; Finding
T9	DISO 276 330	cáncer de pulmón no microcítico (CPNM), no epidermoide
T10	DISO 1822 1830	deleción
#7	AnnotatorNotes T10	C1442161; Gene Deletion Abnormality; Cell or Molecular Dysfunction
T11	PROC 367 391	quimioterapia citotóxica
#8	AnnotatorNotes T11	C0677881; Cytotoxic Chemotherapy; Therapeutic or Preventive Procedure
T12	PROC 429 485	Estudio de fase 3, multicéntrico, aleatorizado y abierto
T13	PROC 501 512	tratamiento
#9	AnnotatorNotes T13	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T14	CHEM 530 542	carboplatino
#10	AnnotatorNotes T14	C0079083; carboplatin; Organic Chemical · Pharmacologic Substance
T15	CHEM 545 555	paclitaxel
#11	AnnotatorNotes T15	C0144576; paclitaxel; Organic Chemical · Pharmacologic Substance
T16	PROC 566 592	tratamiento quimioterápico
T17	DISO 643 652	fumadores
#12	AnnotatorNotes T17	C0337664; Smoker; Finding
T18	DISO 655 667	ex fumadores
#13	AnnotatorNotes T18	C2911355; Personal History of Nicotine Dependence; Finding
T19	DISO 672 726	cáncer de pulmón no microcítico (CPNM), no epidermoide
T20	PROC 763 787	quimioterapia citotóxica
#14	AnnotatorNotes T20	C0677881; Cytotoxic Chemotherapy; Therapeutic or Preventive Procedure
T21	DISO 826 880	Cáncer de pulmón no microcítico (CPNM), no epidermoide
T22	DISO 998 1005	fumador
#15	AnnotatorNotes T22	C0337664; Smoker; Finding
T23	DISO 1008 1018	ex fumador
T24	DISO 1033 1052	CPNM no epidermoide
T25	DISO 1153 1157	CPNM
#16	AnnotatorNotes T25	C0007131; Non-Small Cell Lung Carcinoma; Neoplastic Process
T26	PROC 1179 1199	resección quirúrgica
#17	AnnotatorNotes T26	C0728940; Excision; Therapeutic or Preventive Procedure
T27	PROC 1203 1215	radioterapia
#18	AnnotatorNotes T27	C1522449; Therapeutic radiology procedure; Therapeutic or Preventive Procedure
T28	DISO 1315 1321	lesión
#19	AnnotatorNotes T28	C0221198; Lesion; Finding
T29	DISO 1351 1355	CPNM
#20	AnnotatorNotes T29	C0007131; Non-Small Cell Lung Carcinoma; Neoplastic Process
T30	DISO 1472 1489	hipersensibilidad
#21	AnnotatorNotes T30	C0020517; Hypersensitivity; Pathologic Function | C0429891; Hypersensitivity finding; Finding
T31	CHEM 1501 1511	paclitaxel
#22	AnnotatorNotes T31	C0144576; paclitaxel; Organic Chemical · Pharmacologic Substance
T32	CHEM 1522 1530	fármacos
#23	AnnotatorNotes T32	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T33	CHEM 1557 1587	aceite de ricino polietoxilado
T34	DISO 1624 1641	hipersensibilidad
#24	AnnotatorNotes T34	C0020517; Hypersensitivity; Pathologic Function | C0429891; Hypersensitivity finding; Finding
T35	CHEM 1657 1678	compuestos de platino
#25	AnnotatorNotes T35	C3536919; Platinum Compounds; Chemical Viewed Structurally
T36	DISO 1702 1723	neuropatía periférica
#26	AnnotatorNotes T36	C0031117; Peripheral Neuropathy; Disease or Syndrome
T37	DISO 1754 1770	CPNM epidermoide
T38	DISO 1781 1789	mutación
T39	DISO 1845 1873	mutación L858R en el exón 21
T40	PROC 1946 1970	quimioterapia citotóxica
#27	AnnotatorNotes T40	C0677881; Cytotoxic Chemotherapy; Therapeutic or Preventive Procedure
T41	PROC 1973 1992	quimiorradioterapia
#28	AnnotatorNotes T41	C0436307; Chemoradiotherapy; Therapeutic or Preventive Procedure
T42	DISO 2001 2005	CPNM
#29	AnnotatorNotes T42	C0007131; Non-Small Cell Lung Carcinoma; Neoplastic Process
T43	CHEM 120 129	veliparib
#30	AnnotatorNotes T43	C1958300; veliparib; Organic Chemical · Pharmacologic Substance
T44	CHEM 182 196	quimioterápico
#31	AnnotatorNotes T44	C0003392; Antineoplastic Agents; Organic Chemical · Pharmacologic Substance
T45	ANAT 286 292	pulmón
#32	AnnotatorNotes T45	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T46	ANAT 296 307	microcítico
#33	AnnotatorNotes T46	C1514085; Neoplastic Small Cell; Cell | C1518241; Malignant Small Cell; Cell
T47	DISO 343 354	metastásico
#34	AnnotatorNotes T47	C0027627; Neoplasm Metastasis; Neoplastic Process | C4255448; Metastasis; Pathologic Function
T48	CHEM 516 525	veliparib
#35	AnnotatorNotes T48	C1958300; veliparib; Organic Chemical · Pharmacologic Substance
T49	CHEM 578 592	quimioterápico
#36	AnnotatorNotes T49	C0003392; Antineoplastic Agents; Organic Chemical · Pharmacologic Substance
T50	ANAT 682 688	pulmón
#37	AnnotatorNotes T50	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T51	ANAT 692 703	microcítico
#38	AnnotatorNotes T51	C1514085; Neoplastic Small Cell; Cell | C1518241; Malignant Small Cell; Cell
T52	DISO 739 750	metastásico
#39	AnnotatorNotes T52	C0027627; Neoplasm Metastasis; Neoplastic Process | C4255448; Metastasis; Pathologic Function
T53	ANAT 836 842	pulmón
#40	AnnotatorNotes T53	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T54	ANAT 846 857	microcítico
#41	AnnotatorNotes T54	C1514085; Neoplastic Small Cell; Cell | C1518241; Malignant Small Cell; Cell
T55	DISO 1064 1075	metastásico
#42	AnnotatorNotes T55	C0027627; Neoplasm Metastasis; Neoplastic Process | C4255448; Metastasis; Pathologic Function
T56	PROC 1373 1375	TC
#43	AnnotatorNotes T56	C0040405; X-Ray Computed Tomography; Diagnostic Procedure
T57	CHEM 1589 1598	Cremophor
#44	AnnotatorNotes T57	C0056475; cremophor; Organic Chemical
T58	Date 12 16	2014
T59	LIVB 221 233	investigador
#45	AnnotatorNotes T59	C0035173; Research Personnel; Professional or Occupational Group
T60	LIVB 237 246	pacientes
#46	AnnotatorNotes T60	C0030705; Patients; Patient or Disabled Group
T61	Neg_cue 293 295	no
T62	Neg_cue 316 318	no
T63	LIVB 617 629	investigador
#47	AnnotatorNotes T63	C0035173; Research Personnel; Professional or Occupational Group
T64	LIVB 633 642	pacientes
#48	AnnotatorNotes T64	C0030705; Patients; Patient or Disabled Group
T65	Neg_cue 689 691	no
T66	Neg_cue 712 714	no
T67	Neg_cue 843 845	no
T68	Neg_cue 866 868	no
T69	LIVB 913 921	paciente
#49	AnnotatorNotes T69	C0030705; Patients; Patient or Disabled Group
T70	Age 933 942	≥ 18 años
T71	Duration 970 982	> 12 semanas
T72	LIVB 989 997	paciente
#50	AnnotatorNotes T72	C0030705; Patients; Patient or Disabled Group
T73	Neg_cue 1038 1040	no
T74	LIVB 1130 1138	paciente
#51	AnnotatorNotes T74	C0030705; Patients; Patient or Disabled Group
T76	Neg_cue 1200 1202	ni
T77	LIVB 1284 1292	paciente
#52	AnnotatorNotes T77	C0030705; Patients; Patient or Disabled Group
T78	LIVB 1454 1462	paciente
#53	AnnotatorNotes T78	C0030705; Patients; Patient or Disabled Group
T79	LIVB 1606 1614	paciente
#54	AnnotatorNotes T79	C0030705; Patients; Patient or Disabled Group
T80	LIVB 1684 1692	paciente
#55	AnnotatorNotes T80	C0030705; Patients; Patient or Disabled Group
T81	LIVB 1740 1749	Pacientes
#56	AnnotatorNotes T81	C0030705; Patients; Patient or Disabled Group
T82	Neg_cue 1810 1813	sin
T83	GENE 1835 1842	exón 19
#57	AnnotatorNotes T83	C2736990; EGFR gene exon 19; Gene or Genome
T84	GENE 1899 1906	gen ALK
#58	AnnotatorNotes T84	C1332080; ALK gene; Gene or Genome
T85	LIVB 1913 1921	paciente
#59	AnnotatorNotes T85	C0030705; Patients; Patient or Disabled Group
T87	ANAT 319 330	epidermoide
#60	AnnotatorNotes T87	C0221910; Squamous Epithelial Cells; Cell
T88	ANAT 715 726	epidermoide
#61	AnnotatorNotes T88	C0221910; Squamous Epithelial Cells; Cell
T89	ANAT 869 880	epidermoide
#62	AnnotatorNotes T89	C0221910; Squamous Epithelial Cells; Cell
T75	ANAT 1759 1770	epidermoide
#63	AnnotatorNotes T75	C0221910; Squamous Epithelial Cells; Cell
T90	ANAT 1041 1052	epidermoide
#64	AnnotatorNotes T90	C0221910; Squamous Epithelial Cells; Cell
T91	Neg_cue 1158 1160	no
T86	GENE 1796 1800	EGFR
#65	AnnotatorNotes T86	C1414313; EGFR gene; Gene or Genome
T92	PROC 1091 1124	medios citológicos o histológicos
#66	AnnotatorNotes T92	C1305671; Cytology procedure; Laboratory Procedure + C0344441; Histology Procedure; Laboratory Procedure
A1	Assertion T46 Negated
A2	Assertion T87 Negated
A3	Assertion T88 Negated
A4	Assertion T89 Negated
A5	Assertion T51 Negated
A6	Assertion T54 Negated
A7	Assertion T90 Negated
A8	Assertion T27 Negated
A9	Assertion T26 Negated
A10	Assertion T6 Negated
A11	Status T30 History_of
A12	Status T34 History_of
A13	Status T38 History_of
A14	Status T10 History_of
A15	Status T39 History_of
A16	Status T40 History_of
A17	Status T41 History_of
#67	AnnotatorNotes T1	C1096776; Multicenter Study; Research Activity + C0034656; Randomization; Research Activity + C1709323; Open Label Study; Research Activity 
#68	AnnotatorNotes T5	C0392920; Chemotherapy Regimen; Therapeutic or Preventive Procedure | C3665472; Chemotherapy; Therapeutic or Preventive Procedure
#69	AnnotatorNotes T16	C0392920; Chemotherapy Regimen; Therapeutic or Preventive Procedure | C3665472; Chemotherapy; Therapeutic or Preventive Procedure
#70	AnnotatorNotes T12	C1096776; Multicenter Study; Research Activity + C0034656; Randomization; Research Activity + C1709323; Open Label Study; Research Activity + C0282461; Phase 3 Clinical Trials; Research Activity
#71	AnnotatorNotes T38	C1705285; Mutation Abnormality; Cell or Molecular Dysfunction
#72	AnnotatorNotes T39	C3888903; Point mutation in exon 21 (L858R); Cell or Molecular Dysfunction
#73	AnnotatorNotes T9	C4324656; Non-squamous non-small cell lung cancer; Neoplastic Process
#74	AnnotatorNotes T19	C4324656; Non-squamous non-small cell lung cancer; Neoplastic Process
#75	AnnotatorNotes T21	C4324656; Non-squamous non-small cell lung cancer; Neoplastic Process
#76	AnnotatorNotes T24	C4324656; Non-squamous non-small cell lung cancer; Neoplastic Process
#77	AnnotatorNotes T37	C4324656; Non-squamous non-small cell lung cancer; Neoplastic Process
#78	AnnotatorNotes T33	C0071558; polyethoxylated castor oil; Organic Chemical · Pharmacologic Substance
R1	Negation Arg1:T76 Arg2:T27	
R2	Used_for Arg1:T43 Arg2:T2	
R3	Combined_with Arg1:T43 Arg2:T3	
R4	Combined_with Arg1:T3 Arg2:T4	
R5	Used_for Arg1:T44 Arg2:T5	
R6	Experiences Arg1:T60 Arg2:T2	
R7	Experiences Arg1:T60 Arg2:T5	
R8	Experiences Arg1:T60 Arg2:T7	
R9	Experiences Arg1:T60 Arg2:T8	
R10	Experiences Arg1:T60 Arg2:T9	
R11	Negation Arg1:T61 Arg2:T46	
R12	Negation Arg1:T62 Arg2:T87	
R13	Location_of Arg1:T45 Arg2:T9	
R14	Before Arg1:T9 Arg2:T47	
T93	Quantifier_or_Qualifier 332 340	avanzado
#79	AnnotatorNotes T93	C0205179; Advanced phase; Qualitative Concept | C1522484; metastatic qualifier; Functional Concept
R15	Has_Quantifier_or_Qualifier Arg1:T9 Arg2:T93	
T94	Quantifier_or_Qualifier 728 736	avanzado
#80	AnnotatorNotes T94	C0205179; Advanced phase; Qualitative Concept | C1522484; metastatic qualifier; Functional Concept
R16	Has_Quantifier_or_Qualifier Arg1:T19 Arg2:T94	
R17	Before Arg1:T19 Arg2:T52	
T95	Quantifier_or_Qualifier 1053 1061	avanzado
#81	AnnotatorNotes T95	C0205179; Advanced phase; Qualitative Concept | C1522484; metastatic qualifier; Functional Concept
R18	Has_Quantifier_or_Qualifier Arg1:T24 Arg2:T95	
R19	Before Arg1:T24 Arg2:T55	
R20	Location_of Arg1:T90 Arg2:T24	
R21	Negation Arg1:T73 Arg2:T90	
T96	Quantifier_or_Qualifier 788 803	por primera vez
#82	AnnotatorNotes T96	C1279901; Firstly; Qualitative Concept 
R22	Has_Quantifier_or_Qualifier Arg1:T20 Arg2:T96	
R23	Negation Arg1:T65 Arg2:T51	
R24	Negation Arg1:T66 Arg2:T88	
R25	Location_of Arg1:T50 Arg2:T19	
R26	Experiences Arg1:T64 Arg2:T17	
R27	Experiences Arg1:T64 Arg2:T18	
R28	Experiences Arg1:T64 Arg2:T19	
R29	Overlap Arg1:T7 Arg2:T47	
R31	Overlap Arg1:T8 Arg2:T47	
T97	Quantifier_or_Qualifier 392 407	por primera vez
#83	AnnotatorNotes T97	C1279901; Firstly; Qualitative Concept
R32	Has_Quantifier_or_Qualifier Arg1:T11 Arg2:T97	
R33	Experiences Arg1:T60 Arg2:T11	
R34	Used_for Arg1:T48 Arg2:T13	
R35	Combined_with Arg1:T48 Arg2:T14	
R36	Combined_with Arg1:T14 Arg2:T15	
R37	Experiences Arg1:T64 Arg2:T13	
R38	Experiences Arg1:T64 Arg2:T16	
R39	Used_for Arg1:T49 Arg2:T16	
R40	Overlap Arg1:T17 Arg2:T19	
R41	Overlap Arg1:T18 Arg2:T19	
R42	Overlap Arg1:T7 Arg2:T9	
R44	Experiences Arg1:T64 Arg2:T20	
R45	Negation Arg1:T67 Arg2:T54	
R46	Location_of Arg1:T53 Arg2:T21	
R47	Negation Arg1:T68 Arg2:T89	
R48	Has_Age Arg1:T69 Arg2:T70	
T98	CONC 952 969	Esperanza de vida
#84	AnnotatorNotes T98	C0023671; Life Expectancy; Group Attribute
R49	Has_Duration_or_Interval Arg1:T98 Arg2:T71	
R50	Experiences Arg1:T72 Arg2:T22	
R51	Experiences Arg1:T72 Arg2:T23	
#85	AnnotatorNotes T23	C2911355; Personal History of Nicotine Dependence; Finding
R52	Experiences Arg1:T72 Arg2:T24	
R53	Overlap Arg1:T22 Arg2:T24	
R54	Overlap Arg1:T23 Arg2:T24	
R57	Experiences Arg1:T72 Arg2:T92	
R58	Experiences Arg1:T74 Arg2:T25	
R59	Negation Arg1:T91 Arg2:T26	
R60	Experiences Arg1:T74 Arg2:T26	
R61	Experiences Arg1:T74 Arg2:T27	
T99	Quantifier_or_Qualifier 1216 1235	con fines curativos
R62	Has_Quantifier_or_Qualifier Arg1:T27 Arg2:T99	
A18	Assertion T99 Negated
R63	Negation Arg1:T76 Arg2:T99	
T100	PROC 1256 1265	selección
#86	AnnotatorNotes T100	C0242802; Patient Selection; Research Activity
R64	Overlap Arg1:T25 Arg2:T100	
T101	Quantifier_or_Qualifier 1304 1314	al menos 1
R65	Has_Quantifier_or_Qualifier Arg1:T28 Arg2:T101	
R66	Experiences Arg1:T77 Arg2:T28	
R67	Experiences Arg1:T77 Arg2:T29	
R68	Causes Arg1:T29 Arg2:T28	
T102	Quantifier_or_Qualifier 1337 1347	mensurable
#87	AnnotatorNotes T102	C1513040; Measurable; Functional Concept
R69	Has_Quantifier_or_Qualifier Arg1:T28 Arg2:T102	
T103	Quantifier_or_Qualifier 1322 1336	unidimensional
R70	Has_Quantifier_or_Qualifier Arg1:T28 Arg2:T103	
T104	CONC 1401 1421	RECIST (versión 1.1)
#88	AnnotatorNotes T104	C4086827; Response Evaluation Criteria in Solid Tumors Version 1.1; Intellectual Product
R72	Experiences Arg1:T77 Arg2:T56	
R73	Causes Arg1:T31 Arg2:T30	
R74	Causes Arg1:T32 Arg2:T30	
R75	Causes Arg1:T33 Arg2:T30	
R76	Experiences Arg1:T78 Arg2:T30	
R81	Causes Arg1:T35 Arg2:T34	
R82	Experiences Arg1:T79 Arg2:T34	
T105	Quantifier_or_Qualifier 1727 1736	grado ≥ 2
R83	Has_Quantifier_or_Qualifier Arg1:T36 Arg2:T105	
R84	Experiences Arg1:T80 Arg2:T36	
R85	Location_of Arg1:T75 Arg2:T37	
R86	Experiences Arg1:T81 Arg2:T37	
R87	Experiences Arg1:T81 Arg2:T38	
R88	Location_of Arg1:T86 Arg2:T38	
R89	Negation Arg1:T82 Arg2:T6	
R90	Experiences Arg1:T81 Arg2:T6	
R91	Location_of Arg1:T83 Arg2:T10	
R92	Experiences Arg1:T81 Arg2:T10	
R93	Experiences Arg1:T81 Arg2:T39	
T106	GENE 1866 1873	exón 21
R94	Location_of Arg1:T106 Arg2:T39	
T107	Observation 1880 1906	reordenamiento del gen ALK
#89	AnnotatorNotes T107	C4068350; ALK Gene Rearrangement; Finding
R95	Experiences Arg1:T81 Arg2:T107	
R96	Location_of Arg1:T84 Arg2:T107	
R97	Experiences Arg1:T85 Arg2:T40	
R98	Experiences Arg1:T85 Arg2:T41	
R99	Experiences Arg1:T85 Arg2:T42	
R30	Overlap Arg1:T8 Arg2:T9	
R43	Overlap Arg1:T17 Arg2:T52	
R100	Overlap Arg1:T18 Arg2:T52	
R101	Experiences Arg1:T64 Arg2:T52	
R102	Experiences Arg1:T60 Arg2:T47	
R55	Experiences Arg1:T72 Arg2:T55	
R56	Causes Arg1:T57 Arg2:T30	
#90	AnnotatorNotes T99	C1880198; Cure (remedy); Conceptual Entity
A19	Experiencer T59 Other
A20	Experiencer T60 Patient
A21	Experiencer T63 Other
A22	Experiencer T64 Patient
A23	Experiencer T69 Patient
A24	Experiencer T72 Patient
A25	Experiencer T74 Patient
A26	Experiencer T77 Patient
A27	Experiencer T78 Patient
A28	Experiencer T79 Patient
A29	Experiencer T80 Patient
A30	Experiencer T81 Patient
A31	Experiencer T85 Patient
